NEW
Stock Screener with Intrinsic Value
Regeneron Pharmaceuticals, Inc. (REGN)
Last Price$696.9(5.0%)
Market Cap$75.6B
5.7%
Peers median - 18.8%
24.4%
Peers median - 0.6%
9.2%
Peers median - 8.7%
26.7%
Peers median - (18.0%)
Competing with REGN
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
Compare REGN Valuation Multiples with Peers
Crunching data... Almost there!
Compare REGN Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Regeneron Pharmaceuticals, Inc. (REGN) revenue growth compare to peers and the industry?
Regeneron Pharmaceuticals, Inc. (REGN) revenue growth is 5.7%, compared to the peers' median of 18.8%.
2. How does Regeneron Pharmaceuticals, Inc. (REGN) Free Cash Flow (FCF) margin compare to peers and the industry?
Regeneron Pharmaceuticals, Inc. (REGN) FCF margin is 24.4%, compared to the peers' median of 0.6%.
3. How does Regeneron Pharmaceuticals, Inc. (REGN) Total Debt to Equity ratio compare to peers and the industry?
Regeneron Pharmaceuticals, Inc. (REGN) Total Debt to Equity ratio is 9.2%, compared to the peers' median of 8.7%.
4. How does Regeneron Pharmaceuticals, Inc. (REGN) ROIC (Return on Invested Capital) compare to peers and the industry?
Regeneron Pharmaceuticals, Inc. (REGN) ROIC is 26.7%, compared to the peers' median of (18.0%).